|
A word from the Editor,
Stuart Maddin Welcome to the Skin Therapy Letter. As we look forward to future issues, we will be bringing you new information from authoritative sources concerning the treatment of patients, including material on new and existing drugs that is practical, balanced, and has immediate clinical relevance whether you're a clinical practitioner or hospital-based dermatologist. New formulations, drug interactions, adverse effects, and the latest information on new uses for old drugs will all be covered. We will keep you abreast of treatment advances reported at major dermatology meetings, symposia, and international congresses, and will also draw from years of clinical experience, treatment protocols from centres recognized for their expertise, respected journals, and clinical trials worldwide. The opinions expressed will be balanced and clinically relevant, reflecting the Editor's own experience and extensive drug reporting dating back to the 1960s, and the strong contributions of our international Editorial Advisory Board. We look forward to receiving your feedback. |
Subscription
Information
Annual subscription: Canadian $94 individual; $171 institutional (GST included). US $66 individual; $121 institutional. Outside North America: US$88 individual; $143 institutional. Quotes on multiple subscriptions and student rates supplied upon request. Skin Therapy LetterŪ. (ISSN 1201-5989) Copyright 2004 by SkinCareGuide.com Ltd. All rights reserved. Reproduction in whole or in part by any process in whole or in part is strictly forbidden without prior consent of the publisher in writing. Published ten times yearly by SkinCareGuide.com Ltd., 1004 - 750 West Pender Street, Vancouver, BC , Vancouver, British Columbia, Canada V6C 2T8. Fax: (604) 688-9171, email: info@skintherapyletter.com. |
||
|
Return to Top |